Calaxo Screw Recall
In August 2007, the Food and Drug Administration (FDA) issued a mandatory recall of Calaxo Osteoconductive Interference Screws, only a year after its FDA approval for U.S. release. Calaxo Osteoconductive Interference Screws differ from other medical screw devices because they are designed to be absorbed by the body, as opposed to permanent devices commonly used in knee surgeries. Manufactured and marketed by Smith & Nephew, an orthopedic medical device company, Calaxo bone screws are intended to encourage bone growth and regeneration.
The recall follows reports of the screws breaking and leaving fragments in the surrounding tissue in patients who had the bioabsorbable screws implanted in their knees during anterior cruciate ligament (ACL) surgery. Patients often reported suffering from painful swelling, infection and fluid buildup in repaired knees, which are symptoms of pre-tibial soft tissue swelling.
As a result of the splintering of the device, some patients had to undergo local debridement, which requires the surgical removal of affected tissue and/or bone. This surgical procedure can often be expensive and cause patients extreme discomfort during the recovery period.
Calaxo Bone Screw Lawsuits
Patients who have undergone surgical procedures that used recalled Calaxo bone screws are entitled to compensation to recover expenses for necessary medical procedures. In many instances, patients must undergo additional surgical procedures to address the damage caused by the defective bone screws. Patients are also eligible to receive compensation for lost income, lost prospects and pain and suffering.
To learn more about filing a Calaxo lawsuit, contact the highly skilled defective medical device attorneys of Aylstock, Witkin, Kreis and Overholtz at (844) 794-7402 and begin your journey towards rightful compensation.